logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chun-Yen Lin

Chang Gung Memorial Hospital
H指数:44
被引数:7,427

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B

GS-4224在健康受试者和慢性乙型肝炎患者中的安全性、耐受性和药效学研究

Liver International
IF5.2
2026-05-210
PRE
Edward J. Gane; Chi-Yi Chen; Cheng-Hao Tseng; Chun-Yen Lin; Stuart K. Roberts; Dana Tedesco; Frida Abramov; Fangqiu Zhang; Jared M. Odegard; Jeffrey J. Wallin; Naveed A. Shaik; Teri Chew; Latesh Lad; Adele Y. Wang; Scott Balsitis; Simon P. Fletcher; Audrey H. Lau; Wan-Long Chuang; Kosh Agarwal
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C

高正常值范围及异常丙氨酸转氨酶水平与慢性丙型肝炎治疗后肝癌风险增加相关

Journal of the Formosan Medical Association
IF2.5
2026-04-012
OAAI
Chen, Yen-Chun; Tsai, Pei-Chien; Huang, Chung-Feng; Chen, Chi-Yi; Hung, Chao-Hung; Chen, Chien-Hung; Tai, Chi-Ming; Cheng, Pin-Nan; Kuo, Hsing Tao; Mo, Lein-Ray; Lo, Ching Chu; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Pei-Lun; Bair, Ming-Jong; Chang, Te-Sheng; Lin, Chun-Yen; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Yang, Tzeng-Hue; Peng, Cheng-Yuan; Yang, Chi-Chieh; Chong, Lee-Won; Lin, Chih-Wen; Chu, Cheng-Hsin; Tsai, Ming-Chang; Kao, Jia-Horng; Liu, Chun-Jen; Chuang, Wan-Long; Tseng, Kuo-Chih; Yu, Ming-Lung
Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

质子束疗法提升了阿替利珠单抗/贝伐珠单抗在晚期肝细胞癌中的疗效：一项倾向性评分分析

Liver International
IF5.2
2025-12-020
PRE
Yuan-Hung Kuo; Wei Teng; Po-Ting Lin; Yen-Hao Chen; Chung-Wei Su; Eric Yi-Liang Shen; Bing-Shen Huang; Tsung-Han Wu; Jen-Yu Cheng; Yi-Chung Hsieh; Wei-Ting Chen; Chao-Hung Hung; Shi-Ming Lin; Chen-Chun Lin; Jing-Houng Wang; Chun-Yen Lin
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis

预后营养指数预测接受阿替利珠单抗和贝伐珠单抗治疗的肝细胞癌患者结局：一项倾向性评分匹配分析

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY
IF4.2
2025-12-010
PRE
Kuo, Yuan-Hung; Teng, Wei; Chen, Yen-Hao; Lin, Po -Ting; Wu, Tsung-Han; Su, Chung-Wei; Chen, Wei-Ting; Lin, Chen-Chun; Hung, Chao-Hung; Lu, Sheng-Nan; Lin, Shi-Ming; Wang, Jing-Houng; Lin, Chun-Yen
Lenvatinib versus sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: the LEVIATHAN Study

伦伐替尼对比索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌的二线治疗：LEVIATHAN 研究

JHEP Reports
IF7.5
2025-09-230
OAAI
Pasquale Lombardi; Jung Sun Kim; Giulia F. Manfredi; Ciro Celsa; Claudia A.M. Fulgenzi; Antonio D’Alessio; Bernardo Stefanini; Niraj C. Doshi; Emily Warmington; Thomas U. Marron; Matthias Pinter; Bernhard Scheiner; Beodeul Kang; Ho Yeong Lim; Wei-Fan Hsu; Brooke Wietharn; Marianna Silletta; Alessandro Parisi; Chun-Yen Lin; Andrea Dalbeni; Gianluca Masi; Martin Schönlein; Johann von Felden; Fabio Piscaglia; Peter R. Galle; Masatoshi Kudo; Tiziana Pressiani; Lorenza Rimassa; Mario Pirisi; Giuseppe Cabibbo; Hong Jae Chon; David J. Pinato
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan

将病毒学抑制的慢性乙型肝炎合并肾功能/肝功能不全患者转换为替诺福韦艾拉酚胺：台湾地区II期研究子分析

Journal of the Formosan Medical Association
IF2.5
2025-07-300
OA
Chun-Jen Liu; Young-Suk Lim; Chi-Yi Chen; Chien-Hung Chen; Yi-Hsiang Huang; Chun-Yen Lin; Chun-Che Lin; Ming-Lung Yu; Frida Abramov; Leland J. Yee; Ran Duan; John F. Flaherty; Wei-Wen Su; Sheng-Shun Yang; Harry L.A. Janssen; Wan-Long Chuang
Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH)

慢性丙型肝炎患者抗病毒治疗成功后抑郁症的长期风险及风险因素的影响：一项全国性真实世界台湾队列研究（T-COACH）

Journal of the Formosan Medical Association
IF2.5
2025-06-090
OAAI
Ping-Jen Hu; Ming-Lung Yu; Ming-Yao Chen; Chi-Yi Chen; Hsing-Tao Kuo; Chao-Hung Hung; Kuo-Chih Tseng; Hsueh-Chou Lai; Cheng-Yuan Peng; Jing-Houng Wang; Jyh-Jou Chen; Pei-Lun Lee; Rong-Nan Chien; Chi-Chieh Yang; Gin-Ho Lo; Jia-Horng Kao; Chun-Jen Liu; Chen-Hua Liu; Sheng-Lei Yan; Chun-Yen Lin
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C

Hong, C.-M.; Su, T.-H.; Hsu, S.-J.; Tseng, T.-C.; Liu, C.-H.; Yang, H.-C.; Kao, J.-H.; Chen, P.-J.; Cheng, P.-N.; Hung, C.-H.; 等. 将中性粒细胞与淋巴细胞比值加入Pre-DAA FIB-4不会增加对丙型肝炎患者新发肝并发症的预测价值。中华医事杂志. 2024; 已录用. [Google Scholar] [CrossRef] [PubMed]

Journal of the Formosan Medical Association
IF2.5
2024-11-020
OAAI
Chun-Ming Hong; Tung-Hung Su; Shih-Jer Hsu; Tai-Chung Tseng; Chen-Hua Liu; Hung-Chih Yang; Jia-Horng Kao; Pei-Jer Chen; Pin-Nan Cheng; Chao-Hung Hung; Cheng-Yuan Peng; Chien-Hung Chen; Chun-Yen Lin; Hsing-Tao Kuo; Han-Chieh Lin; Yi-Hsiang Huang; Chi-Yi Chen; Chih-Lin Lin; Pei-Chien Tsai; Yu-Syuan Zeng

研究方向

暂未获取到该数据
I
I‐Shyan Sheen
H 指数:52论文数:302被引数:9,513
C
Chien‐Hao Huang
H 指数:19论文数:108被引数:1,208
R
Rong‐Nan Chien
H 指数:48论文数:347被引数:1.9万
W
Wen‐Juei Jeng
H 指数:33论文数:208被引数:4,344
M
Ming‐Lung Yu
H 指数:71论文数:888被引数:2.2万
C
Ching‐Tai Huang
H 指数:27论文数:145被引数:2,251
J
Jia‐Horng Kao
H 指数:92论文数:1,109被引数:4.3万
Y
Yi‐Hsiang Huang
H 指数:63论文数:824被引数:2.3万
P
Pin‐Nan Cheng
H 指数:29论文数:176被引数:4,263
C
Cheng‐Yuan Peng
H 指数:47论文数:413被引数:1.0万